Serina Therapeutics's total assets for Q3 2024 were $7.43M, a decrease of -30.57% from the previous quarter. SER total liabilities were $21.26M for the fiscal quarter, a -21.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.